
HHS withdraws Trump administration policy that limited FDA review of certain Covid-19 tests
CNN
The Biden administration is withdrawing a policy established under the Trump administration that limited the US Food and Drug Administration's review process of certain lab tests, including some Covid-19 tests. The US Department of Health and Human Services announced the withdrawal on Monday.
Last year, the Trump administration determined that the FDA would no longer require premarket review of laboratory-developed tests, known as LDTs. Prior to that determination, laboratories were required to submit applications to develop and use their own Covid-19 tests. But the move to limit that process meant that makers of Covid-19 tests developed by certain labs -- such as Quest Diagnostics, LabCorp or those at academic medical centers -- could distribute their tests without the need to first submit documentation for review by the FDA before they were marketed.

Pipe bomb suspect told FBI he targeted US political parties because they were ‘in charge,’ memo says
The man accused of placing two pipe bombs in Washington, DC, on the eve of the January 6, 2021, riot at the US Capitol told investigators after his arrest that he believed someone needed to “speak up” for people who believed the 2020 election was stolen and that he wanted to target the country’s political parties because they were “in charge,” prosecutors said Sunday.












